The Annexure

News to 16 October 2026 ·

Desk›Chemicals› Neogen Chemicals Ltd

Neogen Chemicals Ltd

BSE 542665 · NSE NEOGEN · ISIN INE136S01016 · Group B · Active

Commodities › Chemicals › Chemicals & Petrochemicals › Specialty Chemicals

₹2,209.85

-0.99%

BSE close, 28 August 2026

Market cap

₹6,050.94 cr

2.7 cr shares · Small cap

Free float

₹2,765.97 cr

as published

P/E · P/B

115.9× · 7.71×

EPS ₹19.06 · BV ₹286.62

FY25-26 rev / PAT

855.49 / 46.96

₹ cr, as filed

Filings, window

22

4 selected · 18%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹978.00 52-WK HIGH ₹2,482.70 ₹2,209.85 82% of range
Against 52-week high-11.0%
Against 52-week low+126.0%
Day change-0.99%
Size bandSmall cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹19.06
Price / earnings115.94×
Price / book7.71×
Book value — derived, price ÷ P/B₹286.62
Return on equity6.64%
Operating margin22.22%
Net margin7.71%

Consistency check

P/B ÷ P/E, which must equal ROE
6.65%
ROE as published
6.64%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 252.28 19.44 7.15 22.22% 7.71%
Mar-26 · Q 248.63 14.66 5.56 19.81% 5.90%
FY25-26 855.49 46.96 17.81 19.53% 5.49%

Quarter on quarter

Revenue, quarter on quarter
+1.5%
Net profit, quarter on quarter
+32.6%
Operating margin, quarter on quarter
+241 bps

Disclosure profile 22 filings in the window

0 median 16.0 sector max 59 22 83th percentile of 300 Chemicals filers
Shaded is the middle half of the sector, 12 to 20 filings. Measured against the 300 Chemicals companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Fundraising3
Press Release1
Selected sub-total4
Procedural
General5
Analyst / Investor Meet3
AGM / EGM2
SAST2
Allotment1
Annual Report1
BRSR1
Book Closure1
Newspaper Publication1
Trading Window1
Procedural sub-total18
Total22

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 98 trading days

22 filings · 4 selected · busiest 2026-07-30

Filing rhythm · the twelve most recent

2026-08-312026-09-25

SelectedProcedural

Filings

22 in the window · 22 earlier on record

  1. 25 September 2026 ·

    Trading Window

    Closure of Trading Window

    Intimation of closure of trading window

    Insider Trading / SAST / Closure of Trading Window View filing →

  2. 23 September 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Analyst/Investor meet to be held on September 28, 2026.

    Company Update / Analyst / Investor Meet View filing →

  3. 21 September 2026 ·

    Press Release

    Press Release / Media Release

    Press Release titled " Neogen Chemicals raises approx INR 600 crore via its first ever QIP; Issue oversubscribed by 6.5x

    Company Update / Press Release / Media Release View filing →

  4. 17 September 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Analyst/Investor meeting to be held on September 22, 2026.

    Company Update / Analyst / Investor Meet View filing →

  5. 17 September 2026 ·

    General

    Outcome Of The Meeting Of The Fund-Raising Committee Held On September 16, 2026

    Outcome of Fund raising Committee meeting approving allotment of equity shares on QIP basis.

    Company Update / General View filing →

  6. 17 September 2026 ·

    Allotment

    Allotment

    Outcome of fund raising committee approving allotment of equity shares on QIP basis.

    Company Update / Allotment of Equity Shares View filing →

  7. 17 September 2026 ·

    Fundraising

    Qualified Institutional Placement

    Outcome of Fund raising committee approving allotment of equity shares on QIP basis

    Company Update / Qualified Institutional Placement View filing →

  8. 16 September 2026 ·

    General

    Outcome Of Fund Raising Committee

    Outcome of Fund raising committee held today approving closure of issue, issue price, placement document, and confirmation of allocation note

    Company Update / General View filing →

  9. 16 September 2026 ·

    Fundraising

    Qualified Institutional Placement

    Outcome of Fund Raising Committee held today approving closure of issue, issue price, placement document and confirmation of allocation note.

    Company Update / Qualified Institutional Placement View filing →

  10. 10 September 2026 ·

    General

    Outcome Of Fund Raising Committee Meeting Held Today

    Approval of Issue opening date and Floor price and PPD.

    Company Update / General View filing →

  11. 10 September 2026 ·

    Fundraising

    Qualified Institutional Placement

    Outcome of Fund raising committee meeting held today for opening of QIP issue.

    Company Update / Qualified Institutional Placement View filing →

  12. 31 August 2026 ·

    General

    Disclosure Pursuant To Regulation 30 (9) Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations').

    Approval for execution of Business Transfer Agreement between NIL and NML for sale/ transfer of undertaking/ assets as mentioned in detail in BTA by NIL to NML.

    Company Update / General View filing →

  13. 21 August 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Proceedings of the 37th AGM.

    AGM/EGM / AGM View filing →

  14. 20 August 2026 ·

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SBI Mutual Fund

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  15. 20 August 2026 ·

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SBI Mutual Fund

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  16. 30 July 2026 ·

    Newspaper Publication

    Newspaper Publication

    Notice of 37th AGM to be held on 21-08-2026 in newspaper publication.

    Company Update / Newspaper Publication View filing →

  17. 30 July 2026 ·

    Book Closure

    Intimation Of Book Closure Period And Record Date For 37Th AGM To Be Held On 21-08-2026.

    Intimation of book closure period and record date for 37th AGM to be held on 21-08-2026.

    Corp. Action / Book Closure View filing →

  18. 30 July 2026 ·

    BRSR

    Business Responsibility and Sustainability Reporting (BRSR)

    BRSR and BRSR Assurance Report FY 2025-26.

    Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →

  19. 30 July 2026 ·

    AGM / EGM

    Notice Of 37Th AGM And Integrated Annual Report For FY 2025-26

    Notice of 37th AGM and Integrated Annual Report for FY 2025-26.

    AGM/EGM / AGM View filing →

  20. 30 July 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    Integrated Report for F.Y. 2025-26

    Others / Reg. 34 (1) Annual Report View filing →

  21. 27 July 2026 ·

    General

    Outcome Of Analysts/ Investors Conference Call - Call Recording.

    Outcome of Analysts/ Investors Conference Call - Call Recording.

    Company Update / General View filing →

  22. 27 July 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Outcome

    Earnings conference call recording.

    Company Update / Analyst / Investor Meet View filing →

RSS feed for Neogen Chemicals Ltd · the 50 most recent filings